CombiMatrix Looks to Spend $10M Stock Placement on Dx Business | GenomeWeb
CombiMatrix stands to pocket $10 million in the coming days after its parent company Acacia Research received commitments from investors to buy 9.8 million units of equity for $1.02 apiece, the company said this week.
CombiMatrix CEO Amit Kumar said the company expects to use the funding to support its diagnostic business with the hope that it will put the company on track to profitability.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.